As this evolutionary process occurs, the average PD-L1 expression potential of the whole tumor increases, which is precisely what our model captures through the dynamic increase of the single epsilon parameter under NHS-muIL12 therapy (Figure 2). This evidence concerns the gene CD274 and neoplasm.